
    
      The post-market study is a prospective, multi-center, single-arm, real world study of the
      Caterpillar™ Arterial Embolization Device. Enrollment will continue until up to fifty (50)
      subjects have been treated with the Caterpillar™ Arterial Embolization Device at up to 20
      investigational sites in the United States.
    
  